Literature DB >> 23949304

Development of a high efficiency dry powder inhaler: effects of capsule chamber design and inhaler surface modifications.

Srinivas R B Behara1, Dale R Farkas, Michael Hindle, P Worth Longest.   

Abstract

PURPOSE: The objective of this study was to explore the performance of a high efficiency dry powder inhaler (DPI) intended for excipient enhanced growth (EEG) aerosol delivery based on changes to the capsule orientation and surface modifications of the capsule and device.
METHODS: DPIs were constructed by combining newly designed capsule chambers (CC) with a previously developed three-dimensional (3D) rod array for particle deagglomeration and a previously optimized EEG formulation. The new CCs oriented the capsule perpendicular to the incoming airflow and were analyzed for different air inlets at a constant pressure drop across the device. Modifications to the inhaler and capsule surfaces included use of metal dispersion rods and surface coatings. Aerosolization performance of the new DPIs was evaluated and compared with commercial devices.
RESULTS: The proposed capsule orientation and motion pattern increased capsule vibrational frequency and reduced the aerosol MMAD compared with commercial/modified DPIs. The use of metal rods in the 3D array further improved inhaler performance. Coating the inhaler and capsule with PTFE significantly increased emitted dose (ED) from the optimized DPI.
CONCLUSIONS: High efficiency performance is achieved for EEG delivery with the optimized DPI device and formulation combination producing an aerosol with MMAD < 1.5 μm, FPF<5 μm/ED > 90%, and ED > 80%.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23949304      PMCID: PMC3946921          DOI: 10.1007/s11095-013-1165-6

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  31 in total

1.  Deagglomeration of dry powder pharmaceutical aerosols.

Authors:  Austin Voss; Warren H Finlay
Journal:  Int J Pharm       Date:  2002-11-06       Impact factor: 5.875

2.  Influence of size and surface roughness of large lactose carrier particles in dry powder inhaler formulations.

Authors:  Martin J Donovan; Hugh D C Smyth
Journal:  Int J Pharm       Date:  2010-09-15       Impact factor: 5.875

3.  A novel dry powder inhaler: Effect of device design on dispersion performance.

Authors:  Parthiban Selvam; Doug McNair; Randall Truman; Hugh D C Smyth
Journal:  Int J Pharm       Date:  2010-08-10       Impact factor: 5.875

Review 4.  Pulmonary formulations: what remains to be done?

Authors:  Jeffry G Weers; John Bell; Hak-Kim Chan; David Cipolla; Craig Dunbar; Anthony J Hickey; Ian J Smith
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2010-12       Impact factor: 2.849

5.  Targeting aerosol deposition to and within the lung airways using excipient enhanced growth.

Authors:  Geng Tian; P Worth Longest; Xiang Li; Michael Hindle
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2013-01-03       Impact factor: 2.849

6.  Performance of combination drug and hygroscopic excipient submicrometer particles from a softmist inhaler in a characteristic model of the airways.

Authors:  P Worth Longest; Geng Tian; Xiang Li; Yoen-Ju Son; Michael Hindle
Journal:  Ann Biomed Eng       Date:  2012-07-21       Impact factor: 3.934

7.  Structural influence of cohesive mixtures of salbutamol sulphate and lactose on aerosolisation and de-agglomeration behaviour under dynamic conditions.

Authors:  Srinivas Ravindra Babu Behara; Paul Kippax; Michelle P McIntosh; David A V Morton; Ian Larson; Peter Stewart
Journal:  Eur J Pharm Sci       Date:  2010-11-26       Impact factor: 4.384

8.  Aerosolization characteristics of dry powder inhaler formulations for the excipient enhanced growth (EEG) application: effect of spray drying process conditions on aerosol performance.

Authors:  Yoen-Ju Son; P Worth Longest; Michael Hindle
Journal:  Int J Pharm       Date:  2013-01-10       Impact factor: 5.875

9.  Condensational growth of combination drug-excipient submicrometer particles for targeted high-efficiency pulmonary delivery: evaluation of formulation and delivery device.

Authors:  Michael Hindle; P Worth Longest
Journal:  J Pharm Pharmacol       Date:  2012-02-21       Impact factor: 3.765

10.  Insight into pressure drop dependent efficiencies of dry powder inhalers.

Authors:  Srinivas Ravindra Babu Behara; Ian Larson; Paul Kippax; Peter Stewart; David A V Morton
Journal:  Eur J Pharm Sci       Date:  2012-06-14       Impact factor: 4.384

View more
  11 in total

1.  Aerosol Drug Delivery During Noninvasive Positive Pressure Ventilation: Effects of Intersubject Variability and Excipient Enhanced Growth.

Authors:  Ross L Walenga; P Worth Longest; Anubhav Kaviratna; Michael Hindle
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2017-01-11       Impact factor: 2.849

2.  Efficient Nose-to-Lung Aerosol Delivery with an Inline DPI Requiring Low Actuation Air Volume.

Authors:  Dale Farkas; Michael Hindle; P Worth Longest
Journal:  Pharm Res       Date:  2018-08-21       Impact factor: 4.200

Review 3.  Use of computational fluid dynamics deposition modeling in respiratory drug delivery.

Authors:  P Worth Longest; Karl Bass; Rabijit Dutta; Vijaya Rani; Morgan L Thomas; Ahmad El-Achwah; Michael Hindle
Journal:  Expert Opin Drug Deliv       Date:  2018-12-10       Impact factor: 6.648

4.  Characterization of a New High-Dose Dry Powder Inhaler (DPI) Based on a Fluidized Bed Design.

Authors:  Dale R Farkas; Michael Hindle; P Worth Longest
Journal:  Ann Biomed Eng       Date:  2015-05-19       Impact factor: 3.934

Review 5.  Drug-targeting methodologies with applications: A review.

Authors:  Clement Kleinstreuer; Yu Feng; Emily Childress
Journal:  World J Clin Cases       Date:  2014-12-16       Impact factor: 1.337

6.  Formulation of High-Performance Dry Powder Aerosols for Pulmonary Protein Delivery.

Authors:  Erin M Wilson; J Christopher Luft; Joseph M DeSimone
Journal:  Pharm Res       Date:  2018-08-23       Impact factor: 4.200

7.  Development of an Inline Dry Powder Inhaler That Requires Low Air Volume.

Authors:  Dale Farkas; Michael Hindle; P Worth Longest
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2017-12-20       Impact factor: 2.849

8.  Development of a new technique for the efficient delivery of aerosolized medications to infants on mechanical ventilation.

Authors:  P Worth Longest; Geng Tian
Journal:  Pharm Res       Date:  2014-08-08       Impact factor: 4.200

9.  Development and comparison of new high-efficiency dry powder inhalers for carrier-free formulations.

Authors:  Srinivas R B Behara; P Worth Longest; Dale R Farkas; Michael Hindle
Journal:  J Pharm Sci       Date:  2013-12-04       Impact factor: 3.534

10.  Performance of dry powder inhalers with single dosed capsules in preschool children and adults using improved upper airway models.

Authors:  Sandra Lindert; Antje Below; Joerg Breitkreutz
Journal:  Pharmaceutics       Date:  2014-02-06       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.